"Cognitive Dysfunction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished or impaired mental and/or intellectual function.
| Descriptor ID |
D060825
|
| MeSH Number(s) |
F03.615.250.700
|
| Concept/Terms |
Cognitive Dysfunction- Cognitive Dysfunction
- Cognitive Dysfunctions
- Dysfunction, Cognitive
- Dysfunctions, Cognitive
- Cognitive Impairments
- Cognitive Impairment
- Impairment, Cognitive
- Impairments, Cognitive
Mild Cognitive Impairment- Mild Cognitive Impairment
- Cognitive Impairment, Mild
- Cognitive Impairments, Mild
- Impairment, Mild Cognitive
- Impairments, Mild Cognitive
- Mild Cognitive Impairments
- Mild Neurocognitive Disorder
- Disorder, Mild Neurocognitive
- Disorders, Mild Neurocognitive
- Mild Neurocognitive Disorders
- Neurocognitive Disorder, Mild
- Neurocognitive Disorders, Mild
Cognitive Decline- Cognitive Decline
- Cognitive Declines
- Decline, Cognitive
- Declines, Cognitive
- Mental Deterioration
- Deterioration, Mental
- Deteriorations, Mental
- Mental Deteriorations
|
Below are MeSH descriptors whose meaning is more general than "Cognitive Dysfunction".
Below are MeSH descriptors whose meaning is more specific than "Cognitive Dysfunction".
This graph shows the total number of publications written about "Cognitive Dysfunction" by people in this website by year, and whether "Cognitive Dysfunction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cognitive Dysfunction" by people in Profiles.
-
Dihydromyricetin improves social isolation-induced cognitive impairments and astrocytic changes in mice. Sci Rep. 2022 04 07; 12(1):5899.
-
Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice. Oxid Med Cell Longev. 2021; 2021:5525306.
-
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial. J Alzheimers Dis. 2021; 83(4):1703-1715.
-
Changes in the Auditory Association Cortex in Dementing Illnesses. Otol Neurotol. 2020 12; 41(10):1327-1333.
-
Renal-Cerebral Pathophysiology: The Interplay Between Chronic Kidney Disease and Cerebrovascular Disease. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105461.
-
Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score. PLoS One. 2020; 15(11):e0241707.
-
Antia, a Natural Antioxidant Product, Attenuates Cognitive Dysfunction in Streptozotocin-Induced Mouse Model of Sporadic Alzheimer's Disease by Targeting the Amyloidogenic, Inflammatory, Autophagy, and Oxidative Stress Pathways. Oxid Med Cell Longev. 2020; 2020:4386562.
-
Developing a phone-based measure of impairment after acute oral ?9-tetrahydrocannabinol. J Psychopharmacol. 2019 09; 33(9):1160-1169.
-
The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures. Neuropsychol Rev. 2017 12; 27(4):440-484.
-
Insulin resistance and cognitive test performance in elderly adults: National health and nutrition examination survey (NHANES). J Neurol Sci. 2018 05 15; 388:97-102.